Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 49.51%-63.12M | ---- | -256.75%-125.02M | ---- | 27.23%-35.04M | ---- | 60.29%-48.15M | ---19.06M | -54.23%-121.25M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -881.31%-23.32M | ---9.4M | -180.19%-2.38M |
| Investment loss (gain) | ---- | -32,340.68%-1.41M | ---- | --4.37K | ---- | ---- | ---- | ---- | ---- | ---5.77M |
| Impairment and provisions: | ---- | 15.42%5.21M | ---- | -8.72%4.51M | ---- | 178.35%4.94M | ---- | 504.08%1.78M | --641K | -50.75%294K |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 416.04%547K | --298K | -39.08%106K |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 553.72%1.23M | --343K | -55.56%188K |
| -Other impairments and provisions | ---- | 45.13%1.44M | ---- | --991.79K | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -666.34%-88.46K | ---- | --15.62K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | 118.47%8.31K | ---- | 80.18%-45K | ---- | -266.13%-227K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 118.47%8.31K | ---- | 80.18%-45K | ---- | -266.13%-227K |
| Depreciation and amortization: | ---- | 8.32%12.1M | ---- | 6.57%11.17M | ---- | 25.83%10.48M | ---- | 51.93%8.33M | --3.94M | 59.88%5.48M |
| -Amortization of intangible assets | ---- | -6.44%1.74M | ---- | -11.73%1.86M | ---- | 18.14%2.11M | ---- | 4.64%1.78M | --844K | 16.95%1.7M |
| Financial expense | ---- | 0.71%-49.72M | ---- | 22.45%-50.08M | ---- | -379,971.05%-64.58M | ---- | -94.48%17K | --2K | -0.96%308K |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 682.01%16.48M | --864K | 1,232.80%2.11M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -89.87%11.26M | --11.47M | 113.02%111.18M |
| Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -228.24%-33.65M | ---11.55M | 55.78%-10.25M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -157.43%-12.46M | ---- | 161.28%21.7M | ---- | -117.40%-35.41M | ---- | -64.69%-16.29M | ---5.34M | -374.39%-9.89M |
| Accounts receivable (increase)decrease | ---- | -117.99%-59.28M | ---- | -55.32%-27.19M | ---- | 6.07%-17.51M | ---- | -426.70%-18.64M | ---5.41M | -19.08%-3.54M |
| Accounts payable increase (decrease) | ---- | 264.29%42.12M | ---- | -36.10%11.56M | ---- | -19.86%18.09M | ---- | 310.12%22.58M | --3.98M | -25.54%5.51M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,444.98%-15.99M | --332K | 133.43%478K |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -196.38%-5.54M | ---1.25M | 65.46%5.75M |
| Cash from business operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -465.07%-67.53M | ---19.23M | 36.44%-11.95M |
| Interest received - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 881.31%23.32M | --9.4M | 180.19%2.38M |
| Special items of business | ---- | 1,750.42%6M | ---- | 12,842.79%324.52K | ---- | --2.51K | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | 105.78%4.43M | 17.39%-126.65M | -141.01%-76.64M | -28.83%-153.32M | -20.21%-31.8M | ---119.01M | ---26.46M | ---- | ---- | ---- |
| Net cash from operations | 105.78%4.43M | 21.14%-120.65M | -141.01%-76.64M | -28.56%-153M | -20.21%-31.8M | -169.16%-119.01M | -169.21%-26.46M | -361.79%-44.22M | ---9.83M | 46.67%-9.58M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%10M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%10M | --10M | ---10M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.46%45K | ---- | 529.03%390K |
| Purchase of fixed assets | 19.48%-33.67M | -190.08%-83.24M | -939.99%-41.81M | 3.64%-28.7M | 71.31%-4.02M | -69.22%-29.78M | -136.11%-14.01M | 31.40%-17.6M | ---5.94M | 10.21%-25.66M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,907.14%-1.12M | ---182K | 98.56%-28K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -49.59%106.36M | --95M | 39.97%211M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6.32%-195.5M |
| Other items in the investment business | -141.96%-102.96M | 139.92%204.39M | 157.73%245.39M | -42.36%-512.01M | ---425.09M | ---359.66M | ---- | ---- | --922K | 162.51%8.57M |
| Net cash from investment operations | -167.11%-136.63M | 122.41%121.16M | 147.44%203.59M | -38.84%-540.7M | -2,962.24%-429.11M | -498.66%-389.44M | -114.04%-14.01M | 8,094.11%97.69M | --99.81M | 98.72%-1.22M |
| Net cash before financing | -204.14%-132.2M | 100.07%510.4K | 127.54%126.94M | -36.43%-693.7M | -1,038.96%-460.91M | -1,050.88%-508.46M | -144.98%-40.47M | 595.25%53.47M | --89.98M | 90.45%-10.8M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 50.00%30M | --49M | --20M | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%10M |
| Refund | ---- | ---49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---20M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.66B | ---- | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 94.69%-17K | ---2K | -7.02%-320K |
| Dividends paid - financing | ---61.67K | ---663.01K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 467.79%521.8M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---83.01M | ---10.13M | ---- |
| Other items of the financing business | 76.97%-3.33M | -38.46%-32.49M | -5,009.10%-14.46M | -14.06%-23.46M | 98.64%-282.94K | ---20.57M | ---20.79M | ---- | ---- | ---- |
| Net cash from financing operations | 379.92%26.61M | -41.28%-33.15M | 2,059.62%5.54M | -14.06%-23.46M | 98.64%-282.94K | -101.31%-20.57M | -104.34%-20.79M | 207.89%1.57B | ---10.17M | 406.84%511.28M |
| Effect of rate | -324.24%-5.42M | 456.54%5.88M | -25.39%2.41M | -106.08%-1.65M | -76.90%3.24M | 264.47%27.1M | 1,721.88%14.01M | -682.01%-16.48M | ---864K | -1,232.80%-2.11M |
| Net Cash | -179.70%-105.59M | 95.45%-32.64M | 128.73%132.49M | -35.56%-717.16M | -652.94%-461.2M | -132.50%-529.03M | -176.75%-61.25M | 225.22%1.63B | --79.81M | 4,195.91%500.48M |
| Begining period cash | -7.32%338.68M | -66.30%365.44M | -66.30%365.44M | -31.64%1.08B | -49.59%1.08B | 193.85%1.59B | 298.48%2.15B | 1,202.98%539.8M | --539.8M | -22.51%41.43M |
| Cash at the end | -54.50%227.67M | -7.32%338.68M | -20.11%500.34M | -66.30%365.44M | -70.23%626.29M | -49.59%1.08B | 240.00%2.1B | 298.48%2.15B | --618.74M | 1,202.98%539.8M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.